V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 190008274 | 190006880 | 1.8 | 59.2 | Curative (C) | null | 2019-03-08 | Docetaxel 100mg/m2 (21 day) | null | null | CISPLATIN + FLUOROURACIL | 101354029 |
| 190008280 | 190006881 | 1.71 | 52 | Curative (C) | 2018-01-06 | 2018-08-16 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 101068024 |
| 190008284 | 190006882 | 1.62 | 74 | Palliative (P) | 2017-12-22 | 2017-12-23 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | null | NIVOLUMAB | 100816262 |
| 190008310 | 190006883 | 1.72 | 82.4 | Neo-adjuvant (N) | 2018-06-05 | 2018-06-17 | EW EuroEwing 2012 Arm A VAI | 02 | N | CNS ATRT DOX | 101569305 |
| 190008338 | 190006884 | 1.53 | 36.35 | Palliative (P) | 2021-01-13 | 2021-01-17 | Cyclophosphamide + Topotecan | 02 | N | PACLITAXEL | 100290628 |
| 190008339 | 190006885 | 1.78 | 53.7 | null | 2022-03-20 | 2022-03-27 | CARBOPLATIN + ETOPOSIDE | 02 | N | CEMIPLIMAB | 100681399 |
| 190008345 | 190006886 | 1.85 | 68.6 | null | 2021-10-25 | 2022-03-12 | ETOPOSIDE | 02 | N | BEVACIZUMAB | 101552853 |
| 190008354 | 190006887 | null | 120 | Palliative (P) | 2020-11-29 | 2020-12-20 | Ixazomib + Lenalidomide | 02 | N | CARBOPLATIN + RT | 100182344 |
| 190008359 | 190006888 | 1.76 | 55.8 | Palliative (P) | 2019-07-01 | 2019-07-02 | VAI (Ifos 3g/m2) | 02 | null | GEMCITABINE | 101111083 |
| 190008369 | 190006889 | 0 | 68.7 | Curative (C) | 2017-05-03 | 2017-05-03 | Dox + HD Mtx (post PAM) | null | null | PEMBROLIZUMAB | 100176079 |
| 190008373 | 190006890 | 0 | 77 | Palliative (P) | 2020-08-27 | 2020-09-02 | FLUOROURACIL + IRINOTECAN | 02 | null | TOPOTECAN | 100934867 |
| 190008408 | 190006891 | 1.78 | 70.1 | 03 | 2020-02-09 | 2020-02-22 | NB HRNBL-1 COJEC Ind COURSE C | N | N | CAPECITABINE + OXALIPLATIN | 100845106 |
| 190008417 | 190006892 | 1.78 | 87.4 | Curative (C) | 2018-01-24 | 2018-09-03 | CARBOPLATIN + PACLITAXEL | 01 | null | CARBOPLATIN + PACLITAXEL | 100275307 |
| 190008423 | 190006893 | 1.72 | 125.5 | Neo-adjuvant (N) | null | 2022-02-02 | Cisplatin +Fluorouracil (3 wk) | 01 | N | ATEZOLIZUMAB | 100969447 |
| 190008428 | 190006894 | 1.78 | 89 | Palliative (P) | 2020-07-20 | 2020-08-03 | Sunitinib | null | null | CARBOPLATIN + FLUOROURACIL | 100505133 |
| 190008436 | 190006895 | 1.75 | 66.9 | null | 2019-11-17 | 2019-11-18 | Carboplatin+Fluorouracil 4 or 5 day | 01 | N | CARBOPLATIN + ETOPOSIDE | 100827736 |
| 190008474 | 190006896 | 1.64 | 88.25 | Palliative (P) | 2020-02-01 | 2020-06-04 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 101674078 |
| 190008482 | 190006897 | 1.77 | 92.3 | Palliative (P) | 2019-06-22 | 2019-12-24 | PEMBROLIZUMAB | 02 | null | AVELUMAB | 100200593 |
| 190008489 | 190006898 | 1.45 | 70.1 | Palliative (P) | 2019-06-28 | 2019-07-05 | Cisplatin + Radiotherapy | Y | N | CISPLATIN | 100544585 |
| 190008490 | 190006899 | 1.77 | 85.2 | Curative (C) | 2018-05-03 | 2018-05-05 | Capecitabine | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100139618 |
| 190008496 | 190006900 | 1.7 | 76.3 | Palliative (P) | 2019-11-30 | 2020-07-09 | EW EuroEwing 2012 Arm A VAI | 02 | N | VINORELBINE | 100687980 |
| 190008508 | 190006901 | 0 | 62.5 | null | 2021-09-11 | 2021-11-04 | Trial Unspecified | 02 | N | CAPECITABINE + OXALIPLATIN | 100070073 |
| 190008529 | 190006902 | 0 | 65.1 | Palliative (P) | 2018-07-08 | 2018-07-08 | EURAMOS TRIAL | 02 | N | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 101165907 |
| 190008535 | 190006903 | 1.59 | null | Palliative (P) | 2019-07-29 | 2019-12-14 | VIP | 02 | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100902655 |
| 190008538 | 190006904 | 1.88 | 35 | Adjuvant (A) | 2018-06-28 | 2019-05-30 | Docetaxel 75mg/m2 (21 day) | 02 | null | ENZALUTAMIDE | 100795070 |
| 190008545 | 190006905 | 1.52 | 96.6 | Adjuvant (A) | 2017-03-22 | 2017-09-28 | Doxorubicin + Methotrexate | 02 | N | LOMUSTINE | 101346301 |
| 190008567 | 190006906 | 1.55 | 98.5 | null | 2018-09-14 | 2018-12-11 | CARBOPLATIN + ETOPOSIDE | 02 | Y | NIVOLUMAB | 100150432 |
| 190008572 | 190006907 | 1.63 | 67 | null | 2019-02-04 | 2019-09-02 | Trial Unspecified | null | null | TRIAL UNSPECIFIED | 101317442 |
| 190008575 | 190006908 | 0 | 10.8 | Palliative (P) | 2020-11-23 | 2021-04-16 | Irinotecan + Modified De Gramont | 02 | N | PACLITAXEL | 101320016 |
| 190008579 | 190006909 | 1.73 | 37.5 | Curative (C) | 2021-12-25 | 2022-04-29 | Lenalidomide 25mg (Cycle 1 to 25) | Y | N | NINTEDANIB | 101327356 |
| 190008614 | 190006910 | 1.67 | 62.6 | null | 2020-02-22 | 2020-03-28 | EURAMOS TRIAL | N | N | CISPLATIN + GEMCITABINE + IFOSFAMIDE + PACLITAXEL | 100353650 |
| 190008623 | 190006911 | 1.57 | 52.1 | Curative (C) | 2018-12-17 | 2018-12-31 | OST Mifamurtide | 02 | N | PACLITAXEL | 100687787 |
| 190008626 | 190006912 | 1.69 | 93 | Adjuvant (A) | null | 2018-09-26 | Trabectedin | null | null | ABEMACICLIB + FULVESTRANT | 100506170 |
| 190008638 | 190006913 | 1.56 | 59 | Adjuvant (A) | 2019-06-10 | 2019-06-16 | MAP | 02 | N | FLUOROURACIL | 101067062 |
| 190008644 | 190006914 | 1.65 | 52.65 | Curative (C) | 2021-02-24 | 2021-02-24 | OST Mifamurtide | 02 | N | CETUXIMAB | 101621193 |
| 190008647 | 190006915 | 1.82 | 105.2 | Palliative (P) | 2018-10-03 | 2018-12-20 | EW EuroEwing 2012 Arm A VAC | N | Y | CISPLATIN + RT | 100996805 |
| 190008664 | 190006916 | 0 | 77.7 | null | 2021-10-30 | 2022-04-09 | null | 02 | N | STS NON-RHABDO EPSSG 2005 IFOS DOX | 101867880 |
| 190008671 | 190006917 | 0 | 62.8 | null | 2019-06-20 | 2019-06-21 | EW Rel rEECur Gemcitabine/Docetaxel | 01 | null | CISPLATIN + GEMCITABINE + IFOSFAMIDE + PACLITAXEL | 101855085 |
| 190008677 | 190006918 | 1.69 | 83 | Neo-adjuvant (N) | 2019-10-15 | 2019-12-21 | Carboplatin + Doxorubicin | null | null | EC | 100630635 |
| 190008687 | 190006919 | 1.66 | 77 | Curative (C) | 2018-12-22 | 2018-12-22 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | CISPLATIN + GEMCITABINE | 101280432 |
| 190008693 | 190006920 | 1.82 | 70.4 | null | 2019-08-28 | 2020-05-13 | Cisplatin + Radiotherapy | 02 | N | CISPLATIN | 100593995 |
| 190008716 | 190006921 | 1.59 | null | Curative (C) | 2021-07-10 | 2021-07-14 | NB BEACON Temozolomide Irinotecan | 02 | N | CVD | 100394790 |
| 190008738 | 190006922 | 1.71 | 37.5 | Adjuvant (A) | null | 2018-08-05 | DHAP | 02 | null | FLUOROURACIL + OXALIPLATIN | 101142328 |
| 190008752 | 190006923 | 1.78 | 75.85 | Neo-adjuvant (N) | null | 2020-04-21 | Cisplatin 7 day | 02 | null | CISPLATIN | 100001977 |
| 190008763 | 190006924 | 1.8 | 107.5 | Curative (C) | 2022-03-01 | 2022-03-15 | Cisplatin | 02 | Y | CISPLATIN | 101179629 |
| 190008779 | 190006925 | 1.71 | 49.1 | Neo-adjuvant (N) | 2018-10-22 | 2018-11-05 | NIVOLUMAB | 02 | N | GEMCITABINE | 100199904 |
| 190008787 | 190006926 | 1.75 | 57 | Palliative (P) | 2016-10-28 | 2017-04-11 | CARBOPLATIN + RT | 02 | N | CARBOPLATIN | 101771553 |
| 190008789 | 190006927 | 1.7 | 80 | null | 2015-12-27 | 2016-06-04 | Gemcitabine + Oxaliplatin | 02 | N | NOT MATCHED | 101074975 |
| 190008797 | 190006928 | 1.77 | 90.2 | Disease modification (D) | 2018-11-08 | 2018-12-08 | Cisplatin | 02 | N | CISPLATIN | 100159544 |
| 190008801 | 190006929 | 1.68 | 42.9 | Curative (C) | 2016-01-17 | 2016-08-19 | Cetuximab + Radiotherapy Maint | 01 | N | PACLITAXEL | 100464005 |